PortfoliosLab logoPortfoliosLab logo
RIGL vs. AUGO
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

RIGL vs. AUGO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Rigel Pharmaceuticals, Inc. (RIGL) and Aura Minerals Inc. Common Shares (AUGO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, RIGL achieves a -23.30% return, which is significantly lower than AUGO's 22.99% return.


RIGL

1D
2.40%
1M
2.24%
YTD
-23.30%
6M
-19.45%
1Y
54.23%
3Y*
27.10%
5Y*
-3.96%
10Y*
3.28%

AUGO

1D
7.62%
1M
-22.38%
YTD
22.99%
6M
33.09%
1Y
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

RIGL vs. AUGO - Yearly Performance Comparison


2026 (YTD)2025
RIGL
Rigel Pharmaceuticals, Inc.
-23.30%126.61%
AUGO
Aura Minerals Inc. Common Shares
22.99%111.07%

Correlation

The correlation between RIGL and AUGO is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (All Time)
Calculated using the full available price history since Jul 16, 2025

0.15

Fundamentals

Market Cap

RIGL:

$646.69M

AUGO:

$5.04B

EPS

RIGL:

$19.21

AUGO:

$1.10

PE Ratio

RIGL:

1.71

AUGO:

55.27

PS Ratio

RIGL:

2.08

AUGO:

4.31

PB Ratio

RIGL:

1.62

AUGO:

16.69

Total Revenue (TTM)

RIGL:

$299.77M

AUGO:

$1.14B

Gross Profit (TTM)

RIGL:

$279.95M

AUGO:

$644.49M

EBITDA (TTM)

RIGL:

$125.80M

AUGO:

$394.37M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

RIGL vs. AUGO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RIGL
RIGL Risk / Return Rank: 6767
Overall Rank
RIGL Sharpe Ratio Rank: 6868
Sharpe Ratio Rank
RIGL Sortino Ratio Rank: 7070
Sortino Ratio Rank
RIGL Omega Ratio Rank: 6969
Omega Ratio Rank
RIGL Calmar Ratio Rank: 6565
Calmar Ratio Rank
RIGL Martin Ratio Rank: 6161
Martin Ratio Rank

AUGO

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RIGL vs. AUGO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Rigel Pharmaceuticals, Inc. (RIGL) and Aura Minerals Inc. Common Shares (AUGO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


RIGLAUGODifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

1.20

Calmar ratioReturn relative to maximum drawdown

1.09

Martin ratioReturn relative to average drawdown

1.91

RIGL vs. AUGO - Sharpe Ratio Comparison


Loading charts...

Drawdowns

RIGL vs. AUGO - Drawdown Comparison

The maximum RIGL drawdown since its inception was -99.37%, which is greater than AUGO's maximum drawdown of -50.65%. Use the drawdown chart below to compare losses from any high point for RIGL and AUGO.


Loading charts...

Drawdown Indicators


RIGLAUGODifference

Max Drawdown

Largest peak-to-trough decline

-99.37%

-50.65%

-48.72%

Max Drawdown (1Y)

Largest decline over 1 year

-50.08%

Max Drawdown (3Y)

Largest decline over 3 years

-57.75%

Max Drawdown (5Y)

Largest decline over 5 years

-85.24%

Max Drawdown (10Y)

Largest decline over 10 years

-86.40%

Current Drawdown

Current decline from peak

-96.93%

-43.63%

-53.30%

Average Drawdown

Average peak-to-trough decline

-90.91%

-9.38%

-81.53%

Ulcer Index

Depth and duration of drawdowns from previous peaks

28.64%

Volatility

RIGL vs. AUGO - Volatility Comparison


Loading charts...

Volatility by Period


RIGLAUGODifference

Volatility (1M)

Calculated over the trailing 1-month period

12.05%

Volatility (6M)

Calculated over the trailing 6-month period

36.64%

Volatility (1Y)

Calculated over the trailing 1-year period

69.89%

67.47%

+2.42%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

85.46%

67.47%

+17.99%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

82.81%

67.47%

+15.34%

Dividends

RIGL vs. AUGO - Dividend Comparison

RIGL has not paid dividends to shareholders, while AUGO's dividend yield for the trailing twelve months is around 3.70%.


PositionTTM2025
AUGO
Aura Minerals Inc. Common Shares
3.70%1.61%
RIGL
Rigel Pharmaceuticals, Inc.
0.00%0.00%

Financials

RIGL vs. AUGO - Financials Comparison

This section allows you to compare key financial metrics between Rigel Pharmaceuticals, Inc. and Aura Minerals Inc. Common Shares. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00100.00M200.00M300.00M400.00M20222023202420252026
58.82M
382.61M
(RIGL) Total Revenue
(AUGO) Total Revenue
Values in USD except per share items

RIGL vs. AUGO - Profitability Comparison

The chart below illustrates the profitability comparison between Rigel Pharmaceuticals, Inc. and Aura Minerals Inc. Common Shares over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%40.0%60.0%80.0%100.0%20222023202420252026
92.2%
50.6%
Portfolio components
RIGL - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Rigel Pharmaceuticals, Inc. reported a gross profit of 54.21M and revenue of 58.82M. Therefore, the gross margin over that period was 92.2%.

AUGO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Aura Minerals Inc. Common Shares reported a gross profit of 193.50M and revenue of 382.61M. Therefore, the gross margin over that period was 50.6%.

RIGL - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Rigel Pharmaceuticals, Inc. reported an operating income of 11.89M and revenue of 58.82M, resulting in an operating margin of 20.2%.

AUGO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Aura Minerals Inc. Common Shares reported an operating income of 172.35M and revenue of 382.61M, resulting in an operating margin of 45.1%.

RIGL - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Rigel Pharmaceuticals, Inc. reported a net income of 8.65M and revenue of 58.82M, resulting in a net margin of 14.7%.

AUGO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Aura Minerals Inc. Common Shares reported a net income of 95.16M and revenue of 382.61M, resulting in a net margin of 24.9%.


Frequently Asked Questions


RIGL and AUGO have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for RIGL and AUGO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer